share_log

联康生物科技集团(00690.HK)将于3月27日举行董事会会议以审批全年业绩

Liankang Biotechnology Group (00690.HK) will hold a board meeting on March 27 to approve the annual results

Gelonghui Finance ·  Mar 15 04:52

Gelonghui March 15 | Liankang Biotechnology Group (00690.HK) issued an announcement. The company's board of directors meeting will be held on March 27, 2024 to review and approve the Group's annual results and announcements for the year ended December 31, 2023, and consider the proposal to pay a final dividend (if any).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment